R C Hermida
Overview
Explore the profile of R C Hermida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
553
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sleep-time ambulatory blood pressure as a novel therapeutic target for cardiovascular risk reduction
Hermida R, Ayala D, Mojon A, Smolensky M, Portaluppi F, Fernandez J
J Hum Hypertens
. 2014 Feb;
28(10):567-74.
PMID: 24500721
Diagnosis of hypertension and clinical decisions regarding its treatment are typically based upon daytime clinic blood pressure (BP) measurements, occasionally supplemented by wake-time patient self-assessment. Yet, correlation between BP level...
2.
Fernandez J, Hermida R, Mojon A
Philos Trans A Math Phys Eng Sci
. 2008 Oct;
367(1887):431-45.
PMID: 18940774
Most variables of clinical interest show predictable changes with different frequencies, mainly, but not exclusively, along the rest-activity cycle (circadian variation). Methods of linear least-squares estimation have been designed for...
3.
Kanabrocki E, Ryan M, Hermida R, Ayala D, McCormick J, Dawson S, et al.
Clin Ter
. 2008 Apr;
159(1):35-40.
PMID: 18399261
Objective: The purpose of this study was to examine the circadian distribution of creatinine and uric acid clearances in subjects with Multiple Sclerosis. Materials And Methods: Eleven subjects with MS,...
4.
Kanabrocki E, Hermida R, Torossov M, Haseman M, Bettis K, Young R, et al.
Clin Ter
. 2006 Oct;
157(4):349-54.
PMID: 17051973
A 7-year-old patient with Stage III-c ovarian cancer was subjected to 8 cycles, approximately four weeks apart, of chronobiologically-optimized treatments with combination of three anti-cancer agents: Four cycles at AM,...
5.
Kanabrocki E, Vesely D, Hermida R, Ayala D, Ryan M, Burden J, et al.
Clin Ter
. 2006 Aug;
157(3):241-7.
PMID: 16900851
Hematology variables were measured in blood samples obtained every 3h (8/24h) from 10 multiple sclerosis (MS) patients and 34 healthy subjects and analyzed for circadian characteristics using the population multiple-components...
6.
Martinez-Rey C, Otero-Anton E, Tome S, Rodriguez-Framil M, Gonzalez-Quintela A, Calvo C, et al.
Transplant Proc
. 2005 May;
37(3):1515-6.
PMID: 15866660
Hypertension is a frequent cardiovascular risk factor in liver transplant recipients. The usefulness of ambulatory blood pressure monitoring (ABPM) in these patients is unknown. This study was aimed at evaluating...
7.
Kanabrocki E, Ryan M, Hermida R, Ayala D, Scott G, Murray D, et al.
Chronobiol Int
. 2004 Oct;
21(4-5):739-58.
PMID: 15470965
The free radical nitric oxide (NO*) is involved in a variety of diverse biological processes from acting as a vasodilator in the cardiovascular system to being the rate-limiting component in...
8.
Otero-Anton E, Padin E, Tome S, Gonzalez-Quintela A, Calvo C, Hermida R, et al.
Transplant Proc
. 2003 Mar;
35(2):718.
PMID: 12644109
No abstract available.
9.
Reis F, Hermida R, Souza I, Maldonado J, Tavares P, Fontes-Ribeiro C, et al.
Chronobiol Int
. 2002 Jun;
19(3):599-614.
PMID: 12069040
Coenzyme Q10 (CoQ10) or ubiquinone, a redox component of the mitochondrial electron transport chains, is a powerful antioxidant and membrane stabilizer that may prevent cellular damage during myocardial ischemia and...
10.
Hermida R, Ayala D, Calvo C
Nefrologia
. 2002 May;
22 Suppl 3:59-67.
PMID: 12014304
No abstract available.